BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 33758969)

  • 1. Potentially actionable pharmacogenetic variants and symptom control medications in oncology.
    Patel JN; Boselli D; Jandrisevits EJ; Hamadeh IS; Salem A; Meadors P; Walsh D
    Support Care Cancer; 2021 Oct; 29(10):5927-5934. PubMed ID: 33758969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective Review of Pharmacogenetic Testing at an Academic Children's Hospital.
    Roberts TA; Wagner JA; Sandritter T; Black BT; Gaedigk A; Stancil SL
    Clin Transl Sci; 2021 Jan; 14(1):412-421. PubMed ID: 33048453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proportion of Antipsychotics with CYP2D6 Pharmacogenetic (PGx) Associations Prescribed in an Early Intervention in Psychosis (EIP) Cohort: A Cross-Sectional Study.
    Jameson A; Faisal M; Fylan B; Bristow GC; Sohal J; Dalton C; Sagoo GS; Cardno AG; McLean SL
    J Psychopharmacol; 2024 Apr; 38(4):382-394. PubMed ID: 38494658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing Clinical Utility of Pharmacogenetic Testing in the Military Health System.
    Hellwig LD; Turner C; Olsen C; Libbus J; Markos B; Koehlmoos T; Haigney M; De Castro M; Saunders D
    Mil Med; 2024 Jan; 189(1-2):e198-e204. PubMed ID: 37436924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determining the potential clinical value of panel-based pharmacogenetic testing in patients with chronic pain or gastroesophageal reflux disease.
    Elchynski AL; Cicali EJ; Ferrer Del Busto MC; Hamilton A; Chang KL; Schmidt SO; Weiner B; Davis R; Estores D; Max Smith D; Wiisanen K; Johnson JA; Cavallari LH
    Pharmacogenomics J; 2021 Dec; 21(6):657-663. PubMed ID: 34075203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Pharmacogenomics on Pediatric Psychotropic Medication Prescribing in an Ambulatory Care Setting.
    Tonti E; Lee YM; Gruenke N; Ferren J; Stutzman DL
    J Child Adolesc Psychopharmacol; 2024 Feb; 34(1):52-60. PubMed ID: 38377527
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of drugs with pharmacogenomics (PGx)-based dosing guidelines in a Danish cohort of persons with chronic kidney disease, both on dialysis and not on dialysis: Perspectives for prescribing optimization.
    Westergaard N; Baltzer Houlind M; Christrup LL; Juul-Larsen HG; Strandhave C; Olesen AE
    Basic Clin Pharmacol Toxicol; 2024 Apr; 134(4):531-542. PubMed ID: 38308569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review and meta-analysis of the impacts of germline pharmacogenomics on severe toxicity and symptom burden in adult patients with cancer.
    Lingaratnam S; Shah M; Nicolazzo J; Michael M; Seymour JF; James P; Lazarakis S; Loi S; Kirkpatrick CMJ
    Clin Transl Sci; 2024 May; 17(5):e13781. PubMed ID: 38700261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opportunities for Pharmacogenetic Testing to Guide Dosing of Medications in Youths With Medicaid.
    Tang Girdwood S; Hall M; Antoon JW; Kyler KE; Williams DJ; Shah SS; Orth LE; Goldman J; Feinstein JA; Ramsey LB
    JAMA Netw Open; 2024 Feb; 7(2):e2355707. PubMed ID: 38349656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of targeted vs. expanded pharmacogenomic testing: What are we missing?
    Chambal M; Forsthoffer C; Egnaczyk A; Seitz M; Grande K; Ashcraft K; Wick JA; Blaxall BC
    J Am Pharm Assoc (2003); 2023; 63(3):939-945. PubMed ID: 37024375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of preemptive pharmacogenetic testing and improvement of medication treatment satisfaction among medically underserved patients.
    Lteif C; Eddy E; Terrell J; Cavallari LH; Malaty J; Duarte JD
    Clin Transl Sci; 2024 Jan; 17(1):e13692. PubMed ID: 38013396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomic testing in oncology: a health system's approach to identify oncology provider perspectives.
    Bhatt M; Peshkin BN; Kazi S; Schwartz MD; Ashai N; Swain SM; Smith DM
    Pharmacogenomics; 2023 Nov; 24(16):859-870. PubMed ID: 37942634
    [No Abstract]   [Full Text] [Related]  

  • 13. ADME Gene-Related Pharmacogenomic Labeling of FDA-Approved Drugs: Comparison with Clinical Pharmacogenetics Implementation Consortium (CPIC) Evidence Levels.
    Deb S; Hopefl R; Reeves AA; Cvetkovic D
    Medicines (Basel); 2024 Feb; 11(3):. PubMed ID: 38535119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimated nationwide impact of implementing a preemptive pharmacogenetic panel approach to guide drug prescribing in primary care in The Netherlands.
    Bank PCD; Swen JJ; Guchelaar HJ
    BMC Med; 2019 Jun; 17(1):110. PubMed ID: 31196067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomics for Primary Care: An Overview.
    Rollinson V; Turner R; Pirmohamed M
    Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33198260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Opportunities for Germline Pharmacogenetics and Management of Drug-Drug Interactions in Patients With Advanced Solid Cancers.
    Shugg T; Ly RC; Rowe EJ; Philips S; Hyder MA; Radovich M; Rosenman MB; Pratt VM; Callaghan JT; Desta Z; Schneider BP; Skaar TC
    JCO Precis Oncol; 2022 Feb; 6():e2100312. PubMed ID: 35201852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming Barriers to Discovery and Implementation of Equitable Pharmacogenomic Testing in Oncology.
    Shriver SP; Adams D; McKelvey BA; McCune JS; Miles D; Pratt VM; Ashcraft K; McLeod HL; Williams H; Fleury ME
    J Clin Oncol; 2024 Apr; 42(10):1181-1192. PubMed ID: 38386947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preemptive pharmacogenetic testing to guide chemotherapy dosing in patients with gastrointestinal malignancies: a qualitative study of barriers to implementation.
    Lau-Min KS; Varughese LA; Nelson MN; Cambareri C; Reddy NJ; Oyer RA; Teitelbaum UR; Tuteja S
    BMC Cancer; 2022 Jan; 22(1):47. PubMed ID: 34996412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implementation of preemptive pharmacogenomics in psychiatry.
    Skokou M; Karamperis K; Koufaki MI; Tsermpini EE; Pandi MT; Siamoglou S; Ferentinos P; Bartsakoulia M; Katsila T; Mitropoulou C; Patrinos GP;
    EBioMedicine; 2024 Mar; 101():105009. PubMed ID: 38364700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Landscape of pharmacogenetic variants associated with non-insulin antidiabetic drugs in the Indian population.
    Sivadas A; Sahana S; Jolly B; Bhoyar RC; Jain A; Sharma D; Imran M; Senthivel V; Divakar MK; Mishra A; Mukhopadhyay A; Gibson G; Narayan KV; Sivasubbu S; Scaria V; Kurpad AV
    BMJ Open Diabetes Res Care; 2024 Mar; 12(2):. PubMed ID: 38471670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.